GENEMEDICS APP

GENEMEDICS NUTRITION

Methylene Blue

Author: Dr. George Shanlikian, M.D.  |   Last Updated: November 30th, 2024

Share This Page

Book a Free Consultation

Overall Health Benefits of Methylene Blue

Methylene blue offers a wide range of benefits, including producing anti-aging effects, improving cognitive function, and reducing mortality and morbidity. It also plays a role in enhancing mood, aiding in the treatment of conditions like methemoglobinemia and malaria, improving skin health, and contributing to the fight against infectious diseases and cancer, making it a versatile and valuable compound in various medical applications.

  • Produces anti-aging effects [1-11]
  • Improves cognitive function [12-40]
  • Reduces mortality and morbidity [41-50]
  • Improves mood [51-58]
  • Improves skin health [59-61]
  • Fights various infectious diseases [62-73]
  • Fights cancer and aids in cancer treatment [74-77]
  • Helps treat malaria [78-82]
  • Helps treat methemoglobinemia [83-85]

Key Takeaways of Methylene Blue

  • Methylene blue is a synthetic chemical compound that has been used for centuries as a dye and stain.
  • It has been studied for its potential health benefits, including antioxidant, anti-inflammatory, anticancer, neuroprotective, and metabolic effects.
  • Methylene blue is generally safe when used as directed, but it can cause some side effects depending on the route of administration (by mouth or injection).
  • The dosage of methylene blue depends on the condition being treated. It is important to follow the directions on the label or the instructions of your doctor.

What is Methylene Blue?


Methylene blue, also known as methylthioninium chloride, is a synthetic dye that has been widely used for various purposes, including as a stain in histology and microbiology. Beyond its traditional applications, methylene blue has found its way into the realm of health and medicine due to its unique properties.

Methylene blue was first prepared in 1876 by Heinrich Caro, a German chemist. This medication has a variety of medical and industrial applications. It is on the List of Essential Medicines by the World Health Organization (WHO), which means that it is considered to be an essential medication for a basic health system.

4. How does Methylene Blue Work?


Methylene blue exerts its effects through several mechanisms due to its unique chemical properties. It interacts with various cellular components, leading to a range of potential benefits:

  • Mitochondrial Function: Methylene blue acts as an alternative electron acceptor by facilitating electron transfer in the mitochondrial respiratory chain. It bypasses certain complex deficiencies, enhancing electron flow and preventing electron leakage, which reduces oxidative stress. This mechanism ultimately improves mitochondrial function, promoting cellular energy production and potentially offering therapeutic benefits for neurodegenerative conditions.
  • Antioxidant Activity: Methylene blue acts as an antioxidant, meaning it can neutralize harmful molecules called free radicals that can damage cells and contribute to aging and disease. By scavenging free radicals, it helps protect cells from oxidative stress and potential damage.
  • Nitric Oxide Regulation: Methylene blue can influence the regulation of nitric oxide, a molecule involved in various physiological processes, including blood vessel dilation. By modulating nitric oxide levels, it might have implications for cardiovascular health and blood flow regulation.
  • Neuroprotection: Some studies suggest that methylene blue may offer neuroprotective effects. It can help preserve nerve cells’ viability and function, potentially reducing the risk of neurodegenerative disorders.
  • Cognitive Enhancement: Research indicates that methylene blue might enhance cognitive function by increasing blood flow to the brain and potentially improving memory and attention.
  • Antimicrobial Action: Methylene blue’s ability to interact with cellular components might contribute to its antimicrobial properties. This medication could disrupt bacterial or microbial functions, making it a potential adjunct to traditional antimicrobial therapies.

Chemical Structure of Methylene Blue

Research on Methylene Blue Benefits

A. Produces Anti-Aging Effects


Numerous studies provide empirical evidence supporting the potential anti-aging effects attributed to methylene blue:

  1. Methylene blue (MB) has gained attention for its potential to counteract brain aging, as oxidative metabolism plays a pivotal role in sustaining brain activity. Mitochondrial dysfunction, implicated in neuronal loss and brain diseases like Alzheimer’s and Parkinson’s, underscores the significance of MB’s role. Its lipophilic nature facilitates efficient blood-brain barrier penetration, with higher brain concentration observed after oral or intravenous administration in rats, suggesting its promising anti aging effects. [1]
  2. The process of aging is closely linked to the occurrence of mitochondrial dysfunction, concomitant with heightened levels of free radical production. Methylene blue (MB) exhibits a notable attraction to mitochondria. In contrast to alternative antioxidants like MitoQ and MitoVitE, MB has the capacity to diminish the generation of free radicals not through radical scavenging, but by circumventing the activity of Complex I/III. Notably, in mice and rats, MB can partially reinstate the membrane potential in mitochondria where Complex III function is hindered. [2]
  3. Mitochondria, the cellular powerhouses, play a crucial role in maintaining brain health by producing dopamine, a chemical essential for proper brain function. Dysfunction in these mitochondria due to harmful free radicals can lead to the demise of dopamine-dependent brain cells. This is especially concerning in Parkinson’s disease, an age-related neurodegenerative condition. Interestingly, methylene blue, recognized for enhancing mitochondrial function, shows promise as a potential therapy for Parkinson’s disease, as observed in rat models exposed to rotenone, a substance simulating the disease’s effects. [3-4] These models demonstrated reduced loss of dopamine-producing brain cells and improved motor abilities after the treatment, suggesting a potential avenue for addressing Parkinson’s disease.
  4. In the context of human IMR90 fibroblasts, MB and related diaminophenothiazines extend cellular lifespan by over 20 population doublings, or PDLs. [5] Operating at nanomolar levels, MB effectively postpones cellular senescence by enhancing mitochondrial function, leading to a 30% increase in mitochondrial complex IV and a substantial rise in cellular oxygen consumption by 37-70%. Moreover, MB amplifies heme synthesis, counteracts premature senescence caused by factors like H2O2 or cadmium, and prompts the activation of phase-2 antioxidant enzymes in hepG2 cells. The process of MB transformation between its oxidized and reduced states, facilitated by flavin-dependent enzymes and cytochrome c, contributes to its protective role. This dynamic cycling potentially inhibits mitochondrial oxidant production, mitigating mitochondrial dysfunction and oxidative stress — crucial factors implicated in cellular senescence and aging.
  5. A study investigated the effects of methylene blue (MB) on mitochondrial function in diabetic rat hearts. [6] Researchers observed that MB enhanced mitochondrial respiration and reduced oxidative stress, with benefits dependent on the substrate type. These results indicate MB’s potential as a therapeutic agent to improve cardiac mitochondrial function in diabetes.
  6. Research explored methylene blue (MB) as an anti-aging agent, focusing on its ability to enhance mitochondrial function, reduce oxidative stress, and improve cellular health. [7] The findings highlighted MB’s promise in mitigating age-related cellular decline, supporting its potential applications in anti-aging therapies.
  7. A study examined the neuroprotective effects of methylene blue (MB) in a Parkinson’s disease model. [8] The research found that MB activated the Nrf2 pathway, reducing oxidative stress and improving mitochondrial function in neurons exposed to MPP+ toxicity. These outcomes suggest MB as a potential therapeutic for neurodegenerative diseases.
  8. Research explored the impact of methylene blue (MB) on mitochondrial dysfunction in rat kidneys during acute pancreatitis. [9] The study demonstrated that MB treatment mitigated mitochondrial damage, indicating a protective role for MB in managing renal injury associated with acute pancreatitis.
  9. A review examined the protective potential of methylene blue (MB) in Alzheimer’s disease, highlighting its role in supporting mitochondrial function and enhancing cytochrome c oxidase activity. [10] The analysis underscored MB’s therapeutic promise in addressing mitochondrial dysfunction in neurodegenerative conditions.
  10. Researchers investigated the effects of methylene blue (MB) and mitoquinone on skeletal aging by targeting mitochondrial dysfunction. [11] The study revealed that both compounds improved mitochondrial health and reduced markers of aging in skeletal tissues, suggesting their potential as therapies for skeletal aging-related issues.

B. Improves Cognitive Function


According to studies, methylene blue has demonstrated the potential to enhance cognitive function via several important mechanisms:

  1. A study highlighted the promising benefits of methylene blue on cognitive function. [12] Methylene blue works in a unique way, not relying on traditional drug-receptor interactions. At low doses, it acts as an electron cycler in the mitochondria, the energy powerhouses of cells, boosting antioxidant properties and cell respiration. This enhances nervous system function and memory consolidation, offering potential memory improvement.
  2. A study demonstrated that methylene blue (MB) holds promise in improving cognitive function, especially in conditions linked to reduced blood flow to the brain. [13] Rats with decreased blood flow to the brain showed poorer performance in memory-related tasks, but those treated with daily doses of MB exhibited better memory and learning abilities.
  3. In recent studies, researchers have found that a substance called MB holds promise for protecting the brain, especially by helping the energy factories in our cells, known as mitochondria, work better. [14] This is important for keeping our brain cells healthy. The review also talks about how MB might help the brain make new cells and boost thinking abilities, especially as we get older and our thinking skills decline.
  4. Scientists found that methylene blue can act like an antidepressant, something that helps reduce anxiety, and a protector for the brain. [15] They’ve seen these effects in both animals and humans. One way it helps is by keeping the energy factories in our cells stable and by controlling harmful molecules that can damage our cells.
  5. To comprehend how methylene blue affects Alzheimer’s disease’s progression and uncover its working mechanism, researchers used mice with a condition resembling Alzheimer’s disease. [16] Their study showed that a consistent diet of methylene blue decreased harmful substances associated with Alzheimer’s disease and enhanced the mice’s ability to learn and remember. The way methylene blue seemed to work against these harmful substances involved improving the brain’s waste disposal system.
  6. In a study using rats with symptoms of hepatic encephalopathy (a loss of brain function due to impaired removal of toxins from the blood due to liver damage), researchers tried two treatments: one involving a blue dye called methylene blue (MB) and another using a specific type of light on the head (photobiomodulation or PBM). [17] The results showed that rats with HE-like symptoms treated with methylene blue injection exhibited improved memory, as evidenced by improved performance in water maze tests, compared with rats treated with PBM.
  7. A review of studies reported that methylene blue (MB) is a chemical that can affect different parts of our nervous system by interacting with various molecules involved in how our nerves work. [18] This happens because of its special properties, like how it behaves when it comes to sharing or receiving electrons, its electric charge, and the kind of light it interacts with.
  8. A group of researchers did a study with healthy adults to see if a small amount of methylene blue (MB) taken by mouth could change how different parts of the brain communicate. [19] They used brain scans while the participants were doing tasks and when they were just resting, both before and after they took MB or a fake pill (placebo). The researchers found that oral methylene blue made some parts of the brain work less during a task, and it made other parts of the brain associated with visuomotor tasks, perception, and memory functions communicate better when not doing anything.
  9. A study focused on a potential way to protect and enhance the brain using a specific part of our cells called mitochondria, which are like tiny power plants for the brain. [20] The researchers suggested that improving the way these power plants function could be effectively used to treat diseases like Alzheimer’s, which affect memory and brain function. They have three ideas for how to do this: using certain drugs, using special types of light, and changing our diet to include specific substances.
  10. A substance called methylene blue (MB) was tested in a new study to see if it could help with memory problems in Alzheimer’s patients. [21] The study showed that MB can make brain cells healthier by reducing the harmful Aβ and by making sure amyloid-binding alcohol dehydrogenase (ABAD) doesn’t cause damage to the brain cells. It was tested on mice with brain inflammation and the results were promising. MB not only helped the brain cells survive better, but it also made sure that ABAD didn’t cause issues and improved the levels of another substance called estradiol that’s important for the brain.
  11. A study provided a recent overview of how low amounts of methylene blue and near-infrared light can protect the brain. [22] The study also explained that even though these two methods are different, they both work in the same way by boosting the energy production in cell parts called mitochondria, which helps the brain stay healthy.
  12. A group of researchers investigated how methylene blue, when ingested orally, impacts the brain’s capacity to maintain focus over extended periods and enhance memory in healthy individuals. [23] Employing specialized brain scans, the researchers observed the participants’ brain activity while they undertook tasks assessing focus and memory before and after taking the substance or placebo. Upon analyzing the findings, the researchers discovered that individuals who consumed methylene blue exhibited increased brain activity when concentrating and attempting to recall information, as opposed to those who received the placebo. Furthermore, the participants’ ability to remember information also demonstrated slight improvement.
  13. A study reviewed how methylene blue (MB) impacts different parts of cells and the brain, and how this could be useful for Alzheimer’s disease (AD). [24] It was found that MB can help reduce the buildup of harmful proteins in the brain, improve cell energy production, and influence important brain chemicals. These effects combined might be why MB could be helpful for AD. Scientists are now trying to create new treatments for AD based on these findings.
  14. Previous studies have shown that macroautophagy (a fundamental cellular process that involves the degradation and recycling of cellular components) helps cells stay healthy. In a current study, the researchers showed that methylene blue can safeguard brain cells from dying when they lack essential nutrients, and this protection seems to happen alongside macroautophagy. [25] Interestingly, the researchers found that if they stop macroautophagy, the protective effect of methylene blue goes away.
  15. The use of methylene blue for treating ifosfamide-induced encephalopathy (a side effect of the chemotherapy drug ifosfamide that causes brain dysfunction) was evaluated through a search of MEDLINE and International Pharmaceutical Abstracts. [26] The compound seemed to rapidly alleviate cognitive symptoms of ifosfamide-induced encephalopathy but demonstrated modest efficacy overall.
  16. Researchers reviewed the therapeutic potential of methylene blue in treating traumatic brain injury, brain ischemia, and Alzheimer’s disease. [27] The study highlighted methylene blue’s neuroprotective properties, including its ability to enhance mitochondrial function and reduce oxidative stress. These findings suggest that methylene blue could be a promising candidate for managing various neurodegenerative conditions.
  17. A study investigated the molecular pathways through which methylene blue exerts its neuroprotective effects. [28] The researchers found that methylene blue modulates mitochondrial activity, reduces reactive oxygen species, and influences neurotransmitter systems. These mechanisms collectively contribute to its potential in preventing neuronal damage.
  18. In a randomized controlled trial, scientists examined the impact of methylene blue on brain functional connectivity using fMRI. [29] The results demonstrated that methylene blue administration led to increased connectivity in brain regions associated with memory and attention. This suggests its potential role in enhancing cognitive functions.
  19. Researchers explored the effects of methylene blue on Alzheimer’s disease pathology in transgenic mice. [30] The study revealed that methylene blue inhibited β-secretase activity, reduced amyloid plaque formation, and improved cognitive performance in the mice. These findings indicate its potential as a therapeutic agent for Alzheimer’s disease.
  20. A study investigated methylene blue’s protective effects on the blood-brain barrier during ischemia/reperfusion injury. [31] The findings showed that methylene blue preserved the integrity of the blood-brain barrier and reduced neuronal damage. This suggests its potential in mitigating brain injuries caused by ischemic events.
  21. Researchers explored how methylene blue enhances memory and provides neuroprotection by influencing neurometabolic pathways. [32] The study demonstrated that methylene blue improves mitochondrial function, leading to increased energy production in neurons. These findings suggest potential therapeutic applications for methylene blue in neurodegenerative diseases.
  22. A study investigated the effects of methylene blue on postoperative cognitive disorders in elderly patients undergoing major non-cardiac surgery. [33] The results indicated that methylene blue administration significantly reduced the incidence of early postoperative cognitive dysfunction. This suggests methylene blue could be beneficial in preserving cognitive function post-surgery in elderly patients.
  23. In a study, researchers examined the impact of administering methylene blue after exposure therapy sessions on fear extinction and contextual memory in adults with claustrophobia. [34] The findings revealed that methylene blue enhanced the retention of fear extinction and improved contextual memory. This suggests its potential as an adjunctive treatment in exposure-based therapies for anxiety disorders.
  24. A commentary discussed the methodological considerations of using intravenous methylene blue to mitigate postoperative cognitive disorders in elderly patients. [35] The author emphasized the importance of dosage, timing, and patient selection to maximize the therapeutic benefits of methylene blue. This highlights the need for careful planning in clinical applications to ensure efficacy and safety.
  25. Researchers found that methylene blue administration protected aged mice from cognitive dysfunction induced by sevoflurane anesthesia. [36] The protective effect was attributed to the suppression of Drp1 deSUMOylation, a process involved in mitochondrial dynamics. This study suggests methylene blue’s potential in preventing anesthesia-related cognitive impairments in the elderly.
  26. Researchers investigated the effects of preventive methylene blue treatment on cognitive function in mice expressing human Tau protein associated with neurodegenerative diseases. [37] The results showed that methylene blue preserved cognitive abilities and reduced Tau pathology in these mice. This indicates its potential as a preventive treatment for Tau-related neurodegenerative conditions.
  27. Researchers examined the effects of methylene blue on rats subjected to chronic cerebral hypoperfusion, a condition that mimics vascular dementia. [38] The study found that methylene blue preserved cytochrome oxidase activity, prevented neurodegeneration, and maintained memory function in these rats. These findings suggest its potential in treating vascular-related cognitive impairments.
  28. A study looked into the combined use of focused ultrasound and methylene blue to enhance drug delivery across the blood-brain barrier in a model of Alzheimer’s disease. [39] The treatment led to reduced neural damage and decreased amyloid-beta plaques, associated with upregulation of AQP-4. This approach shows promise for improving therapeutic outcomes in neurodegenerative diseases.
  29. In a study, researchers evaluated both therapeutic and preventive effects of methylene blue on Alzheimer’s disease pathology in transgenic mice. [40] The findings demonstrated that methylene blue treatment reduced amyloid plaques and tau tangles, leading to improved cognitive function. This suggests its potential as a treatment strategy for Alzheimer’s disease.

C. Reduces Mortality and Morbidity


Research indicates that methylene blue has been found to lower both mortality and morbidity rates in individuals affected by a range of medical conditions:

  1. A study looked at patients who experienced low blood pressure after heart surgery, a condition known as cardiac postoperative vasoplegia or vasoplegic syndrome. [41] They found that around 8.8% of these patients had this problem. Unfortunately, it led to higher rates of death (10.7% of those with the issue compared to 3.6% of others). However, when they gave some patients methylene blue, the death rate was much lower (0% vs. 21.4%). Plus, the recovery time was faster with the drug – less than 6 hours compared to more than 48 hours for those who didn’t get it.
  2. Shock that doesn’t respond to fluid and catecholamine therapy is a serious issue with notable harm and fatalities in children. To address this, a study aimed to gather and summarize existing literature while also understanding how doctors employ methylene blue for treating shock in children. [42] They systematically searched various databases for studies involving methylene blue in catecholamine-resistant shock up to 2019. After assessing numerous studies, it was observed that methylene blue generally appeared safe and helped raise blood pressure in refractory shock scenarios caused by various factors.
  3. A systematic review and meta-analysis aimed to assess the effectiveness and safety of methylene blue (MB) in patients with vasodilatory shock. [43] After analyzing 15 studies encompassing 832 patients, it was found that administering MB alongside vasopressors significantly decreased mortality rates and reduced the need for vasopressors. Additionally, MB improved hemodynamics by increasing mean arterial pressure, heart rate, and peripheral vascular resistance. Organ function was positively impacted as well, with a lower incidence of renal failure, and oxygen metabolism was improved through reduced lactate levels. Notably, no serious side effects that require medical attention were observed. These findings suggest that combining MB with vasopressors can enhance survival, hemodynamics, and organ function in vasodilatory shock patients.
  4. Several studies found that methylene blue has been linked to increased mean arterial pressure, decreased need for other medications, reduced length of hospital stay, and improved heart function and oxygenation in patients with septic shock. [44-48]
  5. A study evaluated the effectiveness of methylene blue (MB) in treating vasoplegia (a condition of low blood pressure despite medication) following cardiopulmonary bypass (CPB) during cardiac surgery. [49] The study compared patients who received MB between 2010 and 2015 with matched historical controls from 2004 to 2009. The results showed that the MB group had a significantly shorter time to improvement of vasoplegia, a faster discontinuation of vasopressors, lower 30-day mortality, reduced cardiac surgical Intensive Care Unit (CSICU) morbidity, shorter hospital stays, and a lower incidence of renal failure compared to the control group. The use of MB was associated with improved hemodynamics, decreased need for vasopressors, and better outcomes post-surgery in patients who were at high risk for vasoplegic syndrome.
  6. Researchers investigated whether low-dose methylene blue (MB) could slow down the progression of at-risk brain tissue towards becoming damaged during a stroke. [50] They conducted experiments on rats with a blocked artery and used MRI scans to assess the effects of MB. The study found that MB significantly delayed the transition of at-risk tissue to infarct (damage), moderately improved blood flow to the affected area, and maintained a stable energy supply.

D. Improves Mood


Research studies have demonstrated that methylene blue has shown positive effects on mood:

  1. Studies show that methylene blue can improve mood by inhibiting multiple amine oxidase activities, particularly MAO-A, which increases serotonin. [51-53]
  2. Studies report that methylene blue can treat psychotic and mood disorders, enhance memory in fear-extinction training, and show promise in the short- and long-term management of bipolar disorder. [54-55] Notably, it offers antidepressant and anxiolytic effects in bipolar disorder treatment without inducing manic episodes. Long-term usage has demonstrated improved stabilization and reduced residual symptoms.
  3. The dysfunction of the nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) pathway is closely linked to mood, anxiety, and psychosis in neurobiology. [56] Inhibiting NOS and/or guanylate cyclase has shown antidepressant effects, a mechanism that methylene blue (MB) may leverage for its psychotropic activity.
  4. In one study, five recently developed methylene blue (MB) analogues with low monoamine oxidase-A (MAO-A) activity were examined for their antidepressant-like effects in rats using the forced swim test (FST). [57] The research found that all five analogues demonstrated antidepressant-like properties in the FST, comparable to imipramine and MB, without impacting locomotor activity.
  5. In a 3-week trial, the efficacy of 15 mg/day of methylene blue was assessed against a placebo for severe depressive illness treatment. [58] The study design aimed to prevent both placebo response bias and observer bias. Results indicated that patients receiving methylene blue exhibited significantly greater improvement compared to those on placebo, suggesting its potential as a potent antidepressant at this dosage.

E. Improves Skin Health


Methylene blue has been recognized for its potential anti-aging effects on the skin. Emerging research suggests that the compound’s antioxidant properties and ability to enhance cellular energy production may contribute to improved skin health and appearance:

  1. Methylene blue (MB), a traditional antioxidant targeting mitochondria, effectively scavenged ROS in skin fibroblasts from healthy donors and patients with progeria, a genetic aging disorder. [59] Compared to other general and mitochondrial antioxidants, MB showed enhanced skin fibroblast proliferation, delayed cellular senescence, and passed a skin irritation test on a 3D human skin model. Application of MB improved skin viability, wound healing, hydration, dermis thickness, and altered gene expression of extracellular matrix proteins, suggesting its potential for skin care.
  2. Methylene blue (MB), a historical medicine and antioxidant, has potential as a UV radiation protection ingredient due to its molecular structure and light absorption properties. In one study, the researchers observed that MB treatment reduced DNA damage and cell death caused by UVB rays in human keratinocytes (skin cells). [60] Compared to Oxybenzone, a commonly used sunscreen ingredient harmful to coral reefs, MB showed superior UVB absorption and protection against DNA damage and cellular ROS. Our findings suggest that MB could be a coral reef-friendly sunscreen ingredient offering broad-spectrum UVA and UVB protection.
  3. A study aimed to evaluate the effectiveness and side effects of injecting methylene blue into the perianal skin of patients with chronic refractory idiopathic pruritus ani (IPA), a condition characterized by persistent itching and discomfort in the anal area. [61] Patients who didn’t respond to standard treatments were given intradermal injections of 1% methylene blue solution up to the dentate line, which is the boundary between the upper anal canal and the lower rectum. Results showed that symptoms resolved within 4 weeks, with no serious side effects, and a 20% success rate was observed over a 60-month period.

F. Fights various Infectious Diseases

According to research findings, methylene blue has exhibited the potential to combat a diverse range of infections:

  1. SARS-CoV-2 infection typically initiates within the respiratory tract, leading to bilateral pneumonia. The disease’s progression can result in acute respiratory distress syndrome and multi-organ failure, propelled by viral dissemination through the bloodstream and an exacerbated inflammatory response encompassing a cytokine storm.Methylene blue, a cost-effective dye recognized for its antiseptic properties and employed effectively in treating conditions such as malaria, urinary tract infections, shock, and methemoglobinemia, stands as the singular known substance capable of restraining the excessive generation of reactive species and cytokines, suggesting its potential to treat COVID-19 and SARS-CoV 2 infections. [62-65]
  2. A research aimed to evaluate the safety and efficacy of two distinct urinary antiseptic combinations for addressing recurrent cystitis symptoms. [66] One combination consisted of methenamine 120mg + methylene blue 20mg (Group A), while the other included acriflavine 15mg + methenamine 250mg + methylene blue 20mg + Atropa belladonna L. 15mg (Group B).The study involved participants receiving a 3-day course of oral treatment with the assigned combination, followed by 3 days of antibiotic therapy based on urine culture, alongside continued treatment with the study drug. The Urinary Tract Infection Symptoms Assessment Questionnaire (UTISA) was employed to gauge treatment efficacy, with the primary focus on improvement in the “Urination Regularity” domain.Ultimately, outcomes revealed the effectiveness of both treatments in alleviating UTI symptoms. Notably, the combination of methenamine + methylene blue demonstrated a more favorable profile in terms of treatment-related adverse effects compared to the alternative combination.
  3. A present study systematically investigated methylene blue’s virucidal potential against influenza virus H1N1 and SARS-CoV-2, exploring various factors such as incubation times and the influence of light activation. [67] The research delves into both preventive and therapeutic aspects, probing the impact on infected cells and even in conjunction with immune serum. The data underscores methylene blue’s ability to exert virucidal effects against these viruses at low micromolar concentrations without the need for UV activation.Moreover, the study sheds light on the intricate mechanisms through which methylene blue operates, especially in terms of genomic RNA degradation and the influence of light exposure. In conclusion, this work strongly advocates for clinical investigations to confirm the potential preventive and therapeutic value of methylene blue against both influenza virus H1N1 and SARS-CoV-2 infections.
  4. In addressing the limitations of existing methods for identifying infected tissue in periprosthetic joint infection (PJI), a study aimed to evaluate the efficacy of methylene blue-guided surgical debridement as an innovative approach. [68] This prospective investigation encompassed sixteen patients who met the criteria outlined by the Musculoskeletal Infection Society for PJI, all undergoing the initial stage of a two-stage exchange arthroplasty procedure.Employing a diluted solution of methylene blue (0.1%), the surgical area was infused before debridement, with subsequent analysis of stained and unstained tissue samples collected from various anatomical sites. The application of methylene blue was associated with heightened detection of bacterial presence and increased neutrophil count in stained tissue. These findings underscore the potential utility of methylene blue in visually guiding and enhancing surgical debridement as a treatment strategy for PJI.
  5. Candida albicans is a microorganism known to cause a spectrum of infections, varying from surface-level to systemic fungal infections in individuals with weakened immune systems. An investigation looked into the mechanism by which methylene blue (MB) exerts its antifungal effects against C. albicans. [69] The study demonstrates MB’s efficacy not only against C. albicans but also against two clinical isolates and two non-albicans species.Importantly, MB’s antifungal impact appears to function independently of major drug efflux transporter activity. The research suggests that MB’s influence on Candida cells is linked to mitochondrial inhibition and disturbances in redox balance, leading to disruptions in membrane integrity and lipid composition. Furthermore, the study highlights MB’s ability to hinder the transformation of Candida cells into a more invasive hyphal form, a significant virulence trait. The findings underscore the potential of MB as a promising agent in the fight against fungal infections caused by Candida.
  6. The contamination of blood products with hepatitis C virus (HCV) poses a significant risk, leading to infections that can result in acute and chronic liver diseases. To address this concern, innovative pathogen reduction techniques, specifically employing photodynamic treatment utilizing methylene blue (MB) combined with visible light, as well as shortwave ultraviolet (UVC) irradiation, have been developed. [70] These methods aim to neutralize viruses and other pathogens present in plasma and platelet concentrates (PCs).Cell culture-derived HCV and bovine viral diarrhea virus (BVDV), used as a model for HCV, were subjected to inactivation procedures. Plasma units and PCs were intentionally exposed to high viral titers cultivated in cell cultures. Following treatment with MB and light using the Theraflex MB-Plasma system, or UVC through the Theraflex UV-Platelets system, the residual viral infectivity was meticulously evaluated through sensitive cell culture assays.Results demonstrated that HCV was effectively susceptible to inactivation by both pathogen reduction techniques. Plasma-associated HCV was efficiently neutralized by MB plus light at a mere fraction of the full light dose, effectively rendering it undetectable. In conclusion, the application of technologies such as MB plus light treatment and UVC irradiation exhibits the potential to substantially mitigate the risk of transfusion-transmitted HCV infections, representing a significant advancement in enhancing blood product safety.
  7. In one study, the remarkable efficacy of methylene blue, an FDA-approved drug, as a potent and broad-spectrum antiviral against both Zika and Dengue viruses, has been illuminated both in laboratory settings and animal models. [71] Methylene blue’s capacity to substantially impede the interactions between the viral protease NS3 and its NS2B co-factor, inhibit viral protease activity, curb viral replication, safeguard 3D mini-brain organoids from ZIKV infection, and diminish viremia in a mouse model has been observed.Detailed investigations into the mechanism of action indicate that methylene blue operates during both the viral entry and post-entry phases, suppresses virus production in replicon cells, and hampers the generation of processed NS3 protein. Collectively, these findings underscore methylene blue’s potent antiviral potential for managing flavivirus infections, particularly for Zika virus.
  8. Photodynamic therapy involves the use of a light-activated drug that generates highly reactive radicals upon exposure to specific wavelengths of light. This process, termed “photodynamic antimicrobial chemotherapy” (PACT), holds promise for treating microbial infections. However, conventional application of this therapy for chronic wounds faces challenges due to the presence of thick layers of necrotic tissue, limiting its effectiveness.To address this, a novel approach involving microneedles (MNs) has been investigated, allowing painless and efficient delivery of photosensitizing agents such as methylene blue to the skin. [72] This study aimed to explore the characteristics and antimicrobial activity of dissolving MNs loaded with methylene blue.The results demonstrated significant reduction in microbial viability, exceeding 96% for Staphylococcus aureus and over 99% for Escherichia coli and Candida albicans, when exposed to PACT using methylene blue concentrations ranging from 0.1 to 2.5 mg/mL. This approach exhibited potential for effectively combating various infections through targeted delivery of methylene blue via microneedles.
  9. Bartonella henselae, a Gram-negative bacterium, is transmitted to humans through scratches from cats in the presence of ectoparasites. Infections with this bacterium can lead to various clinical conditions, ranging from local lymph node swelling to more severe systemic diseases like persistent bacteremia (presence of bacteria in the bloodstream) and endocarditis (inflammation of the heart’s lining).Treating persistent B. henselae infections remains challenging, as current treatments are not very effective. In an effort to find better solutions, a study assessed a range of drugs and drug combinations, including those used in current treatments and promising candidates from recent drug screenings. [73] The results showed that ciprofloxacin, gentamicin, and nitrofurantoin were highly effective against stationary phase B. henselae, while clofazimine and miconazole showed poor activity.Notably, combinations of drugs like azithromycin/ciprofloxacin, azithromycin/methylene blue, rifampin/ciprofloxacin, and rifampin/methylene blue demonstrated rapid eradication of stationary phase and biofilm B. henselae. This suggests that combining methylene blue with certain antibiotics can help treat persistent Bartonella infections.

G. Fights Cancer and Aids in Cancer Treatment

According to research studies, methylene blue has shown potential in combating cancer and contributing to cancer treatment strategies.

  1. A study proposed employing poly(N-isopropylacrylamide) (PNIPAM) microgels to encapsulate methylene blue, an anticancer agent, for breast cancer treatment in the MCF-7 cell line. [74] The researchers created biocompatible microgels using nonfunctionalized PNIPAM and its anionically functionalized PNIPAM and polyacrylic acid (PNIPAM-co-PAA) counterparts.Methylene blue was chosen as the photosensitizer due to its ability to produce harmful reactive oxygen species when exposed to light at 664 nm. Notably, core PNIPAM microgels retained methylene blue longer and demonstrated enhanced photodynamic efficacy against MCF-7 cells (human breast cancer cell line), surpassing the performance of free methylene blue.In conclusion, the study highlights the potential of core PNIPAM and core/shell PNIPAM-co-PAA microgels for improving methylene blue encapsulation. Core PNIPAM microgels exhibited controlled drug release and effectively inhibited the growth of MCF-7 cells, showcasing their promise as a platform for enhancing the efficacy of photodynamic therapy.
  2. A study investigated the potential anti-cancer effects of methylene blue (MB), a known inhibitor of Heat shock protein 70 (Hsp70), in comparison to novobiocin (NB), an established Hsp90 inhibitor, and their combination. [75] Lung cancer cells rely on chaperones like Hsp70 and Hsp90 for survival and growth. Through in vitro assays using A549 non-small cell lung cancer cells, MB exhibited lower cell viability compared to NB, and their combination further intensified this effect.The combination demonstrated promising results for inducing early and late apoptosis (programmed cell death). In vivo experiments on benzo[a]pyrene-induced lung carcinogenesis in mice revealed that MB not only significantly inhibited Hsp70 but also improved tumor biomarkers and lung histopathology, suggesting its potent anticancer potential.
  3. A research delved into the effectiveness of methylene blue (MB) in photodynamic therapy (PDT) against breast epithelial cells, representing both non-malignant conditions and diverse molecular subtypes of breast tumors. [76] Cells were subjected to PDT with MB and 640 nm irradiation at 4.5 J/cm², revealing significant tumor cell death while non-malignant cells exhibited greater resistance.Unveiling unique mechanisms beyond conventional apoptosis, the findings pointed towards MB-PDT inducing distinct pathways, including autophagy (a cellular process that involves the degradation and recycling of damaged or unnecessary cellular components), to impact cell viability. Even when inhibiting these pathways, MB-PDT continued to drive cell fatality, demonstrating its potential as an impactful adjunct therapy for breast and potentially other tumor types, with implications for reducing disease recurrence.
  4. Oral mucositis, a complication of cancer therapy, causes severe pain impacting oral function, nutrition, and quality of life, potentially leading to treatment nonadherence and dose-limiting toxicity. Methylene blue (MB) oral rinse has been suggested as a potential solution for this oral pain.In one study, a group of researchers examined 281 patients who had persistent pain despite conventional treatments to assess the efficacy and safety of MB oral rinse for mucositis-related oral pain in cancer patients. [77] The results demonstrated significant pain reduction after MB oral rinse, with most patients achieving relief within the initial three doses. The treatment’s effectiveness remained consistent across various patient factors and cancer types, indicating that MB oral rinse holds promise as an effective and safe approach for managing refractory oral pain caused by mucositis in cancer therapy.

H. Helps Treat Malaria

Malaria is a mosquito-borne infectious disease caused by parasites of the Plasmodium genus and characterized by symptoms like fever, chills, and anemia. Numerous studies have indicated that methylene blue serves as an effective antimalarial agent, demonstrating its potential in the field of malaria treatment:

  1. A review of existing studies confirmed the effectiveness and safety of methylene blue (MB) in treating malaria. [78] While more clinical trials are needed for its effects on P. vivax malaria, strong evidence supports its efficacy against P. falciparum parasites (causative agent of malaria), particularly gametocytes. MB could be an alternative to primaquine (PQ) in falciparum malaria combination therapy, especially for malaria elimination programs, and its addition to artemisinin-based combination therapy (ACT) regimens could decrease transmission intensity, improve treatment outcomes, and reduce the risk of artemisinin and ACT resistance development and spread.
  2. A 2004 study published in the Malaria Journal on the combination of methylene blue and chloroquine (MB-CQ) in 435 children with uncomplicated falciparum malaria in Burkina Faso showed that while CQ monotherapy had a high clinical failure rate in the area in 2003, the combination did not yield favorable results. [79] However, MB alone had some efficacy against malaria. Therefore, it was concluded that MB alone can help treat malaria compared with the MB-CQ combination.
  3. Methylene blue (MB) was the first synthetic antimalarial discovered and used in the late 19th and early 20th centuries against all types of malaria. Studies have shown MB’s effectiveness in inhibiting Plasmodium falciparum, with potent ex vivo activity against drug-resistant isolates. [80] This suggests MB could be a valuable partner drug for artemisinin-based combination therapy (ACT) to prevent resistance and reduce transmission.
  4. A study reported that methylene blue exhibits intrinsic antimalarial activity and can enhance the effectiveness of chloroquine, an antimalarial agent. [81] It’s also important for preventing methemoglobinemia, a complication of malarial anemia. Acting as an antiparasitic agent, methylene blue interferes with hemoglobin and heme metabolism, inhibits Plasmodium falciparum glutathione reductase, and depletes glutathione to sensitize the parasite for chloroquine.
  5. Untreated malaria can rapidly progress to severe forms in less than 24 hours, and drug resistance poses a global threat to malaria prevention efforts. To address this, a group of researchers conducted experiments using methylene blue (MB) in combination with common antimalarial drugs (mefloquine and amodiaquine) to treat malaria and cerebral malaria. [82] The study, using a C57BL6/J mouse model infected with Plasmodium berghei ANKA, showed that MB-based combination therapies were effective even when treatment was initiated at a late stage, with significant survival rate differences observed in comparison to untreated and individual drug-treated groups. Combining MB with AQ proved to be a promising option for preventing cerebral malaria.

I. Helps Treat Methemoglobinemia


Methemoglobinemia is a medical condition characterized by elevated levels of methemoglobin, a modified form of hemoglobin containing ferric iron, in the blood. Hemoglobin, responsible for transporting oxygen in red blood cells, is normally in a ferrous iron state, allowing efficient oxygen binding and release to body tissues. However, in methemoglobin, the iron is oxidized to its ferric state, preventing effective oxygen exchange. At lower levels, one might experience difficulty breathing, nausea, and increased pulse rate, while higher levels can lead to symptoms progressing to lethargy, stupor, declining consciousness, cardiac arrhythmias (abnormal heart rhythms), and even death.

Treatment of methemoglobinemia frequently involves the use of reducing agents, including methylene blue, which is converted to leukomethylene blue (LB). LB acts as a potent reducing agent, facilitating the reduction of ferric iron back to ferrous iron within the methemoglobin molecule. This conversion effectively restores hemoglobin’s ability to transport oxygen, thus remedying the symptoms associated with methemoglobinemia and improving oxygen delivery to body tissues.

Research findings indicate that methylene blue demonstrates therapeutic efficacy in the treatment of methemoglobinemia:

  1. A review explored methylene blue use in treating acquired methemoglobinemia and ifosfamide neurotoxicity, as well as its role in critically ill patients with refractory vasoplegic shock. [83] It has been found effective for treating acquired methemoglobinemia, ifosfamide neurotoxicity, and refractory vasoplegic shock in both pediatric and adult critical care settings, expanding its applications.
  2. A study recommends that the usual starting dose of methylene blue for the treatment of methemoglobinemia is 1–2 mg/kg (0.2 mL/kg of a 1% solution) infused intravenously over 3 to 5 minutes, with the option of a repeated 1 mg/kg dose if needed within 30–60 minutes. [84] However, caution is needed as repeated doses can worsen methemoglobinemia, with toxic levels reached at a total dose > 7 mg/kg, and significant reduction in MetHb levels is expected in less than an hour.
  3. The over-the-counter availability of topical anesthetics and their frequent use in medical procedures like intubation and endoscopy has led to a notable increase in cases of methemoglobinemia in the last decade. Suspicion for methemoglobin should arise in hypoxic and cyanotic patients who show no improvement with 100% FiO2 oxygen therapy. A study recommends methylene blue infusion when methemoglobin levels are 30% for asymptomatic patients and 20% for symptomatic patients. [85]

Methylene Blue Uses

Methylene blue is used for the treatment of the following conditions:

  • Methemoglobinemia: Methylene blue is commonly used to treat methemoglobinemia, a condition where hemoglobin in red blood cells can’t effectively carry oxygen. It helps convert methemoglobin back to normal hemoglobin, enhancing oxygen delivery and improving the capacity to carry oxygen.
  • Cyanide Poisoning: Large doses of methylene blue are utilized in the treatment of cyanide poisoning, helping to counteract the toxic effects by supporting cellular respiration.
  • Septic Shock: Methylene blue has been investigated as an adjunct treatment for septic shock, as it might improve blood pressure regulation and assist in managing shock-related complications.
  • Neurodegenerative Disorders: Methylene blue’s antioxidant and energy-enhancing properties have sparked interest in its potential to mitigate oxidative stress and support mitochondrial function in neurodegenerative conditions like Alzheimer’s and Parkinson’s disease.
  • Cognitive Decline: Some research suggests methylene blue could have cognitive-enhancing effects, making it a candidate for addressing cognitive decline and memory impairment.
  • Ischemic Stroke: Studies have explored methylene blue’s ability to delay the progression of at-risk brain tissue to infarct in certain types of stroke, potentially offering neuroprotective effects.
  • Antimicrobial Therapy: Methylene blue’s antimicrobial properties could be beneficial as an adjunct therapy in combating infections, particularly those caused by antibiotic-resistant bacteria.
  • Mitochondrial Disorders: Due to its potential to support mitochondrial function, methylene blue might be considered for certain mitochondrial disorders where cellular energy production is impaired.
  • Hypotension and Shock: Methylene blue’s ability to stabilize blood pressure, enhance blood flow, and manage refractory hypotension (a severe and persistent drop in blood pressure that does not respond adequately to standard medical interventions) could be valuable in managing various forms of shock.
  • Ifosfamide neuropsychiatric toxicity: Methylene Blue also finds application in addressing ifosfamide neurotoxicity, a lesser-recognized application. The mitochondrial respiratory chain disruption caused by chloroacetaldehyde, a toxic metabolite of ifosfamide, leads to the accumulation of nicotinamide adenine dinucleotide hydrogen (NADH). Methylene blue plays a crucial role in mitigating this neurotoxicity by effectively reversing the NADH inhibition of hepatic gluconeogenesis (a process by which the liver synthesizes glucose from non-carbohydrate sources).

Methylene Blue Contraindications

There are certain situations in which the use of methylene blue is contraindicated, meaning it should be avoided due to potential risks or interactions. Contraindications for methylene blue include:

  • Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency: Individuals with G6PD deficiency are at risk of developing hemolytic anemia (a potentially fatal condition characterized by shortage of healthy red blood cells) when exposed to methylene blue, as the deficiency impairs the ability of red blood cells to handle oxidative stress.
  • Pulmonary Hypertension: Methylene blue should be used with caution or avoided in individuals with pulmonary hypertension, as it can potentially worsen this condition.
  • Preexisting Heart Conditions: Individuals with certain heart conditions, such as certain types of heart failure, should be cautious when using methylene blue, as it can influence cardiac function.
  • Hypertensive Crisis: Methylene blue can cause an increase in blood pressure, so its use should be avoided in individuals with uncontrolled high blood pressure.
  • Allergic Reactions: Individuals with a known hypersensitivity or allergy to methylene blue should avoid its use. Therefore, a health care professional should assess for a history of an allergic reaction to this medication before prescribing it.
  • Pregnancy and Breastfeeding: Methylene blue administration to pregnant women in the second trimester has been linked to fetal death, while unintended exposure in the first trimester might lead to comparatively less fetal damage. The medication is also not recommended for breastfeeding women because it passes into the breast milk.
  • Drug Interactions: When used together with certain medicines for depression such as selective serotonin reuptake inhibitors (SSRIs) and monoamine oxidase inhibitors (MAOI), it can increase the levels of a neurotransmitter (brain chemical) known as serotonin, leading to serious serotonin toxicity or also known as serotonin syndrome. It’s important to discuss all current medications, including dietary supplements, non-prescription drugs, illegal drugs, and other medicines, with a healthcare provider before using methylene blue to prevent serotonin toxicity.
  • Children and Infants: Methylene blue use in children and infants should be approached with caution and under the guidance of a healthcare professional, especially due to the risk of methemoglobinemia.
  • Renal Impairment: Individuals with severe kidney impairment should be cautious when using methylene blue, as it can affect kidney function.

Always consult a healthcare provider before using methylene blue, especially if you have any preexisting medical conditions, are taking dietary supplements, non-prescription drugs and other medicines, or are unsure about its suitability for your specific situation.

Intravenous Methylene Blue vs Oral Methylene Blue Treatment

When it comes to using methylene blue as a treatment, there are two main ways it can be given: intravenous and oral. Intravenous (IV) methylene blue means the substance is injected directly into the bloodstream using a needle, while oral methylene blue is taken by swallowing a pill or liquid.

Intravenous methylene blue is often used in more critical situations or medical settings. It can quickly reach the bloodstream, making it a faster-acting option. This method is commonly used to treat conditions like methemoglobinemia (a blood disorder) or to support certain medical procedures. Because methylene blue injection goes directly into the bloodstream, it can have more immediate effects. However, methylene blue must be injected intravenously very slowly over a period of several minutes to avoid having too much of the compound in one place, which could cause more methemoglobin to form.

On the other hand, oral methylene blue involves taking the substance through the digestive system, like other medications. It is usually used for less urgent situations or chronic conditions. The effects might take longer to appear compared to the IV form because the body needs time to process and absorb the substance through the digestive tract.

Both methods have their own advantages and considerations, and the choice between intravenous and oral methylene blue depends on the specific condition being treated, the desired speed of action, and the overall health of the patient. Always follow the guidance of a health care professional on which form of treatment is best for your situation.

Methylene Blue Side Effects

Methylene blue side effects are very uncommon. There have been some side effects associated with the use of this drug wherein the patient had one of the issues listed below at some point while being on methylene blue. However, these side effects weren’t confirmed to be associated with the treatment and could have been a coincidence and not related to the use of methylene blue.

The side effects of methylene blue can vary depending on whether it’s injected or taken orally. Methylene blue injection might cause local discomfort at the injection site, temporary urine discoloration (blue staining of the urine), an allergic reaction, and skin sensitivity. When taken orally, it could lead to gastrointestinal discomfort, nausea, and possibly discolored stool. Seek medical attention immediately if you experience any untoward signs and symptoms or other side effects.

Methylene Blue Dosage

The dosage of methylene blue can vary depending on the condition being treated. For conditions like methemoglobinemia, a single dose of 1-2 milligrams per kilogram of body weight is often used. However, it’s important to follow the guidance of a medical professional for the correct dosage.

Share This Page

FAQ

What is methylene blue used for?

This medication is used for various purposes, including microbiology staining, potential cognitive enhancement, support for mitochondrial function, antioxidant properties, and as an adjunct in antimicrobial therapies.

Is methylene blue harmful to humans?

Like other medicines, this medication can be safe when used appropriately and under medical guidance of a health care professional. However, improper use or excessive consumption can lead to side effects and potential harm. For instance, methylene blue is known to have the potential to induce hemolytic anemia in individuals with a deficiency of the enzyme glucose-6-phosphate dehydrogenase (G6PD). It can also cause drug interactions when used together with certain medicines for depression or anxiety.

What are the benefits of methylene blue for humans?

Methylene blue’s potential benefits include enhancing cognitive function, supporting mitochondrial health, providing antioxidant effects, aiding in microbial control, and assisting in studying microscopic organisms.

Is methylene blue dye toxic?

This medication can be toxic if consumed at high doses. It’s important to use any form of methylene blue, including the dye, with proper caution and guidance of a health care professional.

Is methylene blue safe for humans?

When used appropriately and under medical supervision, methylene blue is generally considered safe for humans. However, individual reactions and conditions can vary.

Does methylene blue increase oxygen levels?

Yes, this medication has the potential to increase oxygen levels. The way methylene blue works is by changing the oxidized form of hemoglobin (Fe3+) back to its normal form (Fe2+). This helps hemoglobin pick up more oxygen and carry it to the body’s tissues, improving oxygen delivery.

How long does methylene blue last in the body?

The duration of methylene blue’s effects in the body can vary based on factors such as dosage, individual metabolism, and the purpose for which it’s used. It’s best to follow medical guidance.

What is methylene blue used for?

This medication is used for staining in microbiology, potential cognitive enhancement, supporting mitochondrial function, providing antioxidants, and aiding antimicrobial therapies.

Is methylene blue safe for humans?

When used properly and under medical supervision, methylene blue is generally considered safe for humans. However, individual responses may differ.

What are the benefits of methylene blue for humans?

Methylene blue may offer benefits such as cognitive enhancement, support for mitochondria, antioxidant effects, microbial control, and the ability to stain microscopic samples.

What is the common name for methylene blue?

The common name for methylene blue is methylthioninium chloride.

What does methylene blue do for your body?

Methylene blue’s effects on the body include potential cognitive enhancement, support for cellular energy production, antioxidant activity, and assistance in microbial control.

Is methylene blue safe for daily use?

Using methylene blue daily should be done under medical guidance, as excessive or prolonged use might lead to adverse effects. It’s important to follow recommended dosages and usage patterns.

Does methylene blue reduce inflammation?

Methylene blue’s anti-inflammatory effects have been explored in research, but its precise impact on inflammation can vary and further studies are needed.

Is methylene blue good for your liver?

Some studies have suggested that methylene blue might have a protective effect on the liver, but its overall impact depends on various factors and requires more research.

What can methylene blue be used for?

Methylene blue can be used for staining in microbiology, potential cognitive enhancement, supporting mitochondrial function, providing antioxidant effects, and aiding antimicrobial therapies.

What are the benefits of methylene blue for humans?

Potential benefits of methylene blue include cognitive enhancement, support for mitochondria, antioxidant effects, microbial control, and its use as a stain in research.

What does methylene blue detect?

Methylene blue can detect various biological substances and cellular structures when used as a stain in microbiological and histological research.

What does methylene blue do to bacteria?

Methylene blue can stain bacterial cells, making them more visible under a microscope. It’s also been explored for its potential antimicrobial properties.

Who should not take methylene blue?

Individuals with certain medical conditions, such as certain types of glucose-6-phosphate dehydrogenase deficiency, and those on specific medications should avoid methylene blue. Consultation with a healthcare professional is advised to prevent potential adverse effects of the following medications. During the consultation period, it is recommended to tell your doctor if you smoke, drink alcohol, take over the counter medications, or use illegal drugs to avoid any potential interactions.

Avoid taking this medicine with the following medications:

  • Bupropion
  • Certain medicines for depression or anxiety
  • Clomipramine
  • Doxepin
  • Duloxetine
  • Fluoxetine
  • MAOIs like Marplan, Nardil, and Parnate
  • Milnacipran
  • Mirtazapine
  • Rasagiline
  • Selegiline
  • St. John’s wort
  • Trazodone
  • Tryptophan

Is methylene blue safe for daily use?

Using methylene blue daily should be approached cautiously and under medical guidance to prevent potential adverse effects. It’s important to follow recommended usage instructions.

How does methylene blue make you feel?

The effects of methylene blue can vary depending on its purpose and dosage. It’s not meant for recreational use, and any effects should be discussed with a healthcare provider.

How is methylene blue used in medicine?

Methylene blue is used in medicine for various purposes, including treating methemoglobinemia, acting as a diagnostic stain, and potentially offering neuroprotective effects.

What are the applications of methylene blue in staining?

Methylene blue is commonly employed as a stain in histology and microbiology to enhance contrast and visibility of cellular structures.

How does methylene blue treat methemoglobinemia?

Methylene blue helps to turn the abnormal “rusty” form of blood (methemoglobin) back into the normal red form that can carry oxygen effectively.

What are the potential neuroprotective effects of methylene blue?

Methylene blue has shown promise in potentially mitigating neurodegenerative conditions by influencing mitochondrial function and reducing oxidative stress.

How does methylene blue enhance memory function?

Methylene blue has been investigated for its potential to enhance memory and cognitive function, possibly through its effects on mitochondrial function and neurotransmitter systems.

Can methylene blue be used for mood regulation?

Methylene blue has been explored as a potential mood regulator due to its effects on mitochondrial function and interactions with neurotransmitter systems.

What are the industrial applications of methylene blue?

Methylene blue is used in various industries, including textiles, as a dye and colorant, and in analytical chemistry as an indicator.

How is methylene blue used as an indicator in titrations?

In analytical chemistry, methylene blue serves as a redox indicator, undergoing color changes that signal the endpoint of titrations.

What is the role of methylene blue in photodynamic therapy?

Methylene blue is used in photodynamic therapy as a photosensitizer that, when activated by light, produces reactive oxygen species to target and destroy cancer cells.

How does methylene blue interact with other medications?

Methylene blue can interact with certain medications, particularly those affecting serotonin levels, potentially leading to a condition known as serotonin syndrome.

Can methylene blue be used in nanomedicine and drug delivery?

Methylene blue’s properties make it a candidate for applications in nanomedicine and drug delivery, potentially aiding in targeted therapy.

Does methylene blue have antimicrobial properties?

Methylene blue has demonstrated antimicrobial effects against various bacteria, fungi, and parasites, suggesting its potential as an antimicrobial agent.

How does methylene blue affect mitochondrial function?

Methylene blue has been found to influence mitochondrial function by promoting electron transport and enhancing cellular energy production.

What is ifosfamide-induced encephalopathy?

Ifosfamide-induced encephalopathy is a neurological condition associated with the use of ifosfamide chemotherapy.

Is methylene blue used in histological staining?

Yes, methylene blue is commonly used in histological staining to enhance the visualization of cellular structures under a microscope.

What is the relationship between methylene blue and serotonin?

Methylene blue can inhibit the reuptake of serotonin, potentially leading to increased serotonin levels and affecting mood and other physiological processes.

How is methylene blue administered?

Methylene blue can be administered through various routes, including oral, intravenous, and topical application, depending on the intended medical use.

What is the mechanism of action of methylene blue?

Methylene blue’s mechanisms of action include its roles as a redox agent, mitochondrial enhancer, and potential modulator of neurotransmitter systems.

Can methylene blue be used as an antidepressant?

Methylene blue’s effects on neurotransmitters and mitochondrial function have led to investigations into its potential as an adjunctive treatment for depression.

What are the potential future applications of methylene blue?

Methylene blue’s diverse properties open up possibilities for future applications in areas such as neuroprotection, cancer therapy, and drug delivery.

Does methylene blue have antioxidant properties?

Methylene blue exhibits antioxidant properties by reducing oxidative stress and potentially contributing to cellular protection.

How does methylene blue impact cognitive function?

Methylene blue’s influence on mitochondrial function and neurotransmitter systems may contribute to its impact on cognitive function and memory enhancement.

Is methylene blue used in analytical chemistry?

Yes, methylene blue is used as a redox indicator in analytical chemistry to signal the endpoint of titrations.

What is the connection between methylene blue and aquaculture?

Methylene blue is used in aquaculture to treat fungal and bacterial infections in fish, providing a safe environment for aquatic organisms.

How is methylene blue relevant in redox titration?

Methylene blue’s color change in response to redox reactions makes it useful as an indicator in redox titrations.

Can methylene blue be used for cancer treatment?

Methylene blue’s photodynamic properties have led to its investigation as a potential agent for cancer treatment through targeted cell destruction.

What are the safety considerations when using methylene blue?

Methylene blue should be used with caution, considering potential interactions with medications and its adverse effects.

Does methylene blue have potential in drug delivery?

Methylene blue’s properties suggest it could play a role in drug delivery systems, potentially enhancing targeted therapies.

How does methylene blue affect mood disorders?

Methylene blue’s impact on neurotransmitter systems and mitochondrial function has led to its exploration as a potential treatment for mood disorders.

What are the potential drawbacks of methylene blue in therapy?

Drawbacks of methylene blue therapy include potential interactions with medications and adverse effects such as serotonin syndrome.

Can methylene blue be used in combination therapies?

Methylene blue’s diverse mechanisms of action make it a candidate for combination therapies in various medical applications.

How does methylene blue compare to other dyes in staining?

Methylene blue offers distinct staining capabilities compared to other dyes, making it valuable in specific histological and microbiological contexts.

What are the effects of methylene blue on mitochondrial function?

Methylene blue has been shown to enhance mitochondrial function by promoting electron transport and cellular energy production.

Is methylene blue used in veterinary medicine?

Yes, methylene blue is used in veterinary medicine to treat various conditions, including fish parasites and cyanide poisoning.

What role does methylene blue play in oxidative stress?

Methylene blue’s antioxidant properties contribute to its role in mitigating oxidative stress and protecting cells from damage.

How does methylene blue interact with neurotransmitter systems?

Methylene blue interacts with neurotransmitter systems by affecting serotonin reuptake and potentially influencing mood and cognitive function.

What are the potential effects of methylene blue on mood?

Methylene blue’s impact on neurotransmitters and mitochondrial function may lead to mood-enhancing effects.

Can methylene blue be used in targeting cancer cells?

Methylene blue’s photodynamic properties make it a candidate for targeting and destroying cancer cells through light activation.

How is methylene blue relevant to neurodegenerative diseases?

Methylene blue’s potential neuroprotective effects have sparked interest in its application for neurodegenerative disease treatment.

What are the challenges in using methylene blue in therapy?

Challenges in methylene blue therapy include optimizing dosages, understanding potential interactions, and managing adverse effects.

How does methylene blue impact mitochondrial electron transport?

Methylene blue enhances mitochondrial electron transport, potentially leading to increased cellular energy production.

What are the future prospects of methylene blue research?

Future research on methylene blue may uncover new applications and further elucidate its mechanisms of action.

Is methylene blue a versatile compound across different fields?

Yes, methylene blue’s diverse properties make it versatile and applicable in various fields, from medicine to industry.

Reference

  1. Peter C, Hongwan D, Küpfer A, Lauterburg BH. Pharmacokinetics and organ distribution of intravenous and oral methylene blue. Eur J Clin Pharmacol. 2000 Jun;56(3):247-50. doi: 10.1007/s002280000124. PMID: 10952480.

  2. Sváb G, Kokas M, Sipos I, Ambrus A, Tretter L. Methylene Blue Bridges the Inhibition and Produces Unusual Respiratory Changes in Complex III-Inhibited Mitochondria. Studies on Rats, Mice and Guinea Pigs. Antioxidants (Basel). 2021 Feb 16;10(2):305. doi: 10.3390/antiox10020305. PMID: 33669457; PMCID: PMC7920423.

  3. Rojas JC, Simola N, Kermath BA, Kane JR, Schallert T, Gonzalez-Lima F. Striatal neuroprotection with methylene blue. Neuroscience. 2009 Oct 20;163(3):877-89. doi: 10.1016/j.neuroscience.2009.07.012. Epub 2009 Jul 24. PMID: 19596056; PMCID: PMC2765788.

  4. Wen Y, Li W, Poteet EC, Xie L, Tan C, Yan LJ, Ju X, Liu R, Qian H, Marvin MA, Goldberg MS, She H, Mao Z, Simpkins JW, Yang SH. Alternative mitochondrial electron transfer as a novel strategy for neuroprotection. J Biol Chem. 2011 May 6;286(18):16504-15. doi: 10.1074/jbc.M110.208447. Epub 2011 Mar 18. PMID: 21454572; PMCID: PMC3091255.

  5. Atamna H, Nguyen A, Schultz C, Boyle K, Newberry J, Kato H, Ames BN. Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways. FASEB J. 2008 Mar;22(3):703-12. doi: 10.1096/fj.07-9610com. Epub 2007 Oct 10. PMID: 17928358.

  6. Xue H, Thaivalappil A, Cao K. The Potentials of Methylene Blue as an Anti-Aging Drug. Cells. 2021 Dec 1;10(12):3379. doi: 10.3390/cells10123379. PMID: 34943887.

  7. Bhurtel S, Bok E, Katila N, Kim J, Choi DY. Activation of Nrf2 by methylene blue is associated with the neuroprotection against MPP+ induced toxicity via ameliorating oxidative stress and mitochondrial dysfunction. Biochem Pharmacol. 2021 Oct;192:114719. doi: 10.1016/j.bcp.2021.114719. PMID: 34352280.

  8. Kuliaviene I, Baniene R, Virketyte S, Kincius M, Jansen E, Gulbinas A, Kupcinskas L, Trumbeckaite S, Borutaite V. Methylene blue attenuates mitochondrial dysfunction of rat kidney during experimental acute pancreatitis. J Dig Dis. 2016 Mar;17(3):186-92. doi: 10.1111/1751-2980.12328. PMID: 26861116.

  9. Atamna H, Kumar R. Protective role of methylene blue in Alzheimer’s disease via mitochondria and cytochrome c oxidase. J Alzheimers Dis. 2010;20 Suppl 2:S439-52. doi: 10.3233/JAD-2010-100414. PMID: 20463399.

  10. Poudel SB, Frikha-Benayed D, Ruff RR, Yildirim G, Dixit M, Korstanje R, Robinson L, Miller RA, Harrison DE, Strong JR, Schaffler MB, Yakar S. Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging. Aging (Albany NY). 2024 Mar 25;16(6):4948-4964. doi: 10.18632/aging.205147. PMID: 38535998.

  11. Varanasi LK, Jayasankar K, Allen SC, Jenkins JS, Gonzalez-Lima F, Wang H. Methylene blue enhances resilience and energy metabolism under mitochondrial stress in C. elegans. Redox Biol. 2017 Aug;14:260-271. doi: 10.1016/j.redox.2017.07.004. PMID: 28738167.

  12. Rojas JC, Bruchey AK, Gonzalez-Lima F. Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue. Prog Neurobiol. 2012 Jan;96(1):32-45. doi: 10.1016/j.pneurobio.2011.10.007. Epub 2011 Nov 3. PMID: 22067440; PMCID: PMC3265679.

  13. Auchter A, Williams J, Barksdale B, Monfils MH, Gonzalez-Lima F. Therapeutic benefits of methylene blue on cognitive impairment during chronic cerebral hypoperfusion. J Alzheimers Dis. 2014;42 Suppl 4:S525-35. doi: 10.3233/JAD-141527. PMID: 25079810.

  14. Tucker D, Lu Y, Zhang Q. From Mitochondrial Function to Neuroprotection-an Emerging Role for Methylene Blue. Mol Neurobiol. 2018 Jun;55(6):5137-5153. doi: 10.1007/s12035-017-0712-2. Epub 2017 Aug 24. PMID: 28840449; PMCID: PMC5826781.

  15. Alda M. Methylene Blue in the Treatment of Neuropsychiatric Disorders. CNS Drugs. 2019 Aug;33(8):719-725. doi: 10.1007/s40263-019-00641-3. PMID: 31144270.

  16. Medina DX, Caccamo A, Oddo S. Methylene blue reduces aβ levels and rescues early cognitive deficit by increasing proteasome activity. Brain Pathol. 2011 Mar;21(2):140-9. doi: 10.1111/j.1750-3639.2010.00430.x. PMID: 20731659; PMCID: PMC2992595.

  17. Méndez M, Fidalgo C, Arias JL, Arias N. Methylene blue and photobiomodulation recover cognitive impairment in hepatic encephalopathy through different effects on cytochrome c-oxidase. Behav Brain Res. 2021 Apr 9;403:113164. doi: 10.1016/j.bbr.2021.113164. Epub 2021 Feb 4. PMID: 33549685.

  18. Oz M, Lorke DE, Hasan M, Petroianu GA. Cellular and molecular actions of Methylene Blue in the nervous system. Med Res Rev. 2011 Jan;31(1):93-117. doi: 10.1002/med.20177. PMID: 19760660; PMCID: PMC3005530.

  19. Rodriguez P, Singh AP, Malloy KE, Zhou W, Barrett DW, Franklin CG, Altmeyer WB, Gutierrez JE, Li J, Heyl BL, Lancaster JL, Gonzalez-Lima F, Duong TQ. Methylene blue modulates functional connectivity in the human brain. Brain Imaging Behav. 2017 Jun;11(3):640-648. doi: 10.1007/s11682-016-9541-6. PMID: 26961091; PMCID: PMC5018244.

  20. Gonzalez-Lima F, Barksdale BR, Rojas JC. Mitochondrial respiration as a target for neuroprotection and cognitive enhancement. Biochem Pharmacol. 2014 Apr 15;88(4):584-93. doi: 10.1016/j.bcp.2013.11.010. Epub 2013 Dec 4. PMID: 24316434.

  21. Zakaria A, Hamdi N, Abdel-Kader RM. Methylene Blue Improves Brain Mitochondrial ABAD Functions and Decreases Aβ in a Neuroinflammatory Alzheimer’s Disease Mouse Model. Mol Neurobiol. 2016 Mar;53(2):1220-1228. doi: 10.1007/s12035-014-9088-8. Epub 2015 Jan 20. PMID: 25601181.

  22. Gonzalez-Lima F, Auchter A. Protection against neurodegeneration with low-dose methylene blue and near-infrared light. Front Cell Neurosci. 2015 May 12;9:179. doi: 10.3389/fncel.2015.00179. PMID: 26029050; PMCID: PMC4428125.

  23. Rodriguez P, Zhou W, Barrett DW, Altmeyer W, Gutierrez JE, Li J, Lancaster JL, Gonzalez-Lima F, Duong TQ. Multimodal Randomized Functional MR Imaging of the Effects of Methylene Blue in the Human Brain. Radiology. 2016 Nov;281(2):516-526. doi: 10.1148/radiol.2016152893. Epub 2016 Jun 28. PMID: 27351678; PMCID: PMC5084971.

  24. Oz M, Lorke DE, Petroianu GA. Methylene blue and Alzheimer’s disease. Biochem Pharmacol. 2009 Oct 15;78(8):927-32. doi: 10.1016/j.bcp.2009.04.034. Epub 2009 May 9. PMID: 19433072.

  25. Xie L, Li W, Winters A, Yuan F, Jin K, Yang S. Methylene blue induces macroautophagy through 5′ adenosine monophosphate-activated protein kinase pathway to protect neurons from serum deprivation. Front Cell Neurosci. 2013 May 3;7:56. doi: 10.3389/fncel.2013.00056. PMID: 23653592; PMCID: PMC3642497.

  26. Patel PN. Methylene blue for management of Ifosfamide-induced encephalopathy. Ann Pharmacother. 2006 Feb;40(2):299-303. doi: 10.1345/aph.1G114. Epub 2006 Jan 3. PMID: 16391008.

  27. Isaev NK, Genrikhs EE, Stelmashook EV. Methylene blue and its potential in the treatment of traumatic brain injury, brain ischemia, and Alzheimer’s disease. Rev Neurosci. 2024 Mar 27;35(5):585-595. doi: 10.1515/revneuro-2024-0007. PMID: 38530227.

  28. Gureev AP, Sadovnikova IS, Popov VN. Molecular mechanisms of the neuroprotective effect of methylene blue. Biochemistry (Mosc). 2022 Sep;87(9):940-956. doi: 10.1134/S0006297922090073. PMID: 36180986.

  29. Rodriguez P, Singh AP, Malloy KE, Zhou W, Barrett DW, Franklin CG, Altmeyer WB, Gutierrez JE, Li J, Heyl BL, Lancaster JL, Gonzalez-Lima F, Duong TQ. Methylene blue modulates functional connectivity in the human brain. Brain Imaging Behav. 2017 Jun;11(3):640-648. doi: 10.1007/s11682-016-9541-6. PMID: 26961091.

  30. Mori T, Koyama N, Segawa T, Maeda M, Maruyama N, Kinoshita N, Hou H, Tan J, Town T. Methylene blue modulates β-secretase, reverses cerebral amyloidosis, and improves cognition in transgenic mice. J Biol Chem. 2014 Oct 31;289(44):30303-30317. doi: 10.1074/jbc.M114.568212. PMID: 25157105.

  31. Miclescu A, Sharma HS, Martijn C, Wiklund L. Methylene blue protects the cortical blood-brain barrier against ischemia/reperfusion-induced disruptions. Crit Care Med. 2010 Nov;38(11):2199-206. doi: 10.1097/CCM.0b013e3181f26b0c. PMID: 20711066.

  32. Rojas JC, Bruchey AK, Gonzalez-Lima F. Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue. Prog Neurobiol. 2012 Jan;96(1):32-45. doi: 10.1016/j.pneurobio.2011.10.007. PMID: 22067440.

  33. Deng Y, Wang R, Li S, Zhu X, Wang T, Wu J, Zhang J. Methylene blue reduces incidence of early postoperative cognitive disorders in elderly patients undergoing major non-cardiac surgery: An open-label randomized controlled clinical trial. J Clin Anesth. 2021 Feb;68:110108. doi: 10.1016/j.jclinane.2020.110108. PMID: 33091706.

  34. Telch MJ, Bruchey AK, Rosenfield D, Cobb AR, Smits J, Pahl S, Gonzalez-Lima F. Effects of post-session administration of methylene blue on fear extinction and contextual memory in adults with claustrophobia. Am J Psychiatry. 2014 Oct;171(10):1091-8. doi: 10.1176/appi.ajp.2014.13101407. PMID: 25018057.

  35. Nair A. Using intravenous methylene blue to reduce postoperative cognitive disorders in elderly patients—a methodical approach. J Clin Anesth. 2021 Aug;71:110206. doi: 10.1016/j.jclinane.2021.110206. PMID: 33601280.

  36. Zheng F, Fang P, Chang J, Chen M, Zhong Q, Chen T, Chen C, Zhang Z. Methylene blue protects against sevoflurane-induced cognitive dysfunction by suppressing Drp1 deSUMOylation in aged mice. Neurochem Res. 2020 Apr;45(4):956-963. doi: 10.1007/s11064-020-02976-6. PMID: 32008150.

  37. Hochgräfe K, Sydow A, Matenia D, Cadinu D, Könen S, Petrova O, Pickhardt M, Goll P, Morellini F, Mandelkow E, Mandelkow EM. Preventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau. Acta Neuropathol Commun. 2015 May 10;3:25. doi: 10.1186/s40478-015-0204-4. PMID: 25958115.

  38. Auchter AM, Barrett DW, Monfils MH, Gonzalez-Lima F. Methylene blue preserves cytochrome oxidase activity and prevents neurodegeneration and memory impairment in rats with chronic cerebral hypoperfusion. Front Cell Neurosci. 2020 May 20;14:130. doi: 10.3389/fncel.2020.00130. PMID: 32508596.

  39. Choi HJ, Han M, Jung B, Hong YR, Shin S, Lim S, Lee EH, Kim YK, Park J. Methylene blue delivery mediated by focused ultrasound-induced blood-brain barrier disruption reduces neural damage and amyloid-beta plaques by AQP-4 upregulation. Biomedicines. 2022 Dec 8;10(12):3191. doi: 10.3390/biomedicines10123191. PMID: 36551947.

  40. Paban V, Manrique C, Filali M, Maunoir-Regimbal S, Fauvelle F, Alescio-Lautier B. Therapeutic and preventive effects of methylene blue on Alzheimer’s disease pathology in a transgenic mouse model. Neuropharmacology. 2014 Jan;76 Pt A:68-79. doi: 10.1016/j.neuropharm.2013.06.033. PMID: 23891615.

  41. Levin RL, Degrange MA, Bruno GF, Del Mazo CD, Taborda DJ, Griotti JJ, Boullon FJ. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg. 2004 Feb;77(2):496-9. doi: 10.1016/S0003-4975(03)01510-8. PMID: 14759425.

  42. Otero Luna AV, Johnson R, Funaro M, Canarie MF, Pierce RW. Methylene Blue for Refractory Shock in Children: A Systematic Review and Survey Practice Analysis. Pediatr Crit Care Med. 2020 Jun;21(6):e378-e386. doi: 10.1097/PCC.0000000000002295. PMID: 32453920.

  43. Zhao CC, Zhai YJ, Hu ZJ, Huo Y, Li ZQ, Zhu GJ. Efficacy and safety of methylene blue in patients with vasodilatory shock: A systematic review and meta-analysis. Front Med (Lausanne). 2022 Sep 26;9:950596. doi: 10.3389/fmed.2022.950596. PMID: 36237547; PMCID: PMC9552293.

  44. Gachot B, Bedos JP, Veber B, Wolff M, Regnier B. Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock. Intensive Care Med. 1995 Dec;21(12):1027-31. doi: 10.1007/BF01700666. PMID: 8750129.

  45. Daemen-Gubbels CR, Groeneveld PH, Groeneveld AB, van Kamp GJ, Bronsveld W, Thijs LG. Methylene blue increases myocardial function in septic shock. Crit Care Med. 1995 Aug;23(8):1363-70. doi: 10.1097/00003246-199508000-00009. PMID: 7634806.

  46. Ibarra-Estrada M, Kattan E, Aguilera-González P, Sandoval-Plascencia L, Rico-Jauregui U, Gómez-Partida CA, Ortiz-Macías IX, López-Pulgarín JA, Chávez-Peña Q, Mijangos-Méndez JC, Aguirre-Avalos G, Hernández G. Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial. Crit Care. 2023 Mar 13;27(1):110. doi: 10.1186/s13054-023-04397-7. PMID: 36915146; PMCID: PMC10010212.

  47. Paciullo CA, McMahon Horner D, Hatton KW, Flynn JD. Methylene blue for the treatment of septic shock. Pharmacotherapy. 2010 Jul;30(7):702-15. doi: 10.1592/phco.30.7.702. PMID: 20575634.

  48. Luis-Silva F, Menegueti MG, Sepeda CDR, Petroski-Moraes BC, Sato L, Peres LM, Becari C, Basile-Filho A, Evora PRB, Martins-Filho OA, Auxiliadora-Martins M. Effect of methylene blue on hemodynamic and metabolic response in septic shock patients. Medicine (Baltimore). 2022 Jan 21;101(3):e28599. doi: 10.1097/MD.0000000000028599. PMID: 35060528; PMCID: PMC8772761.

  49. Habib AM, Elsherbeny AG, Almehizia RA. Methylene Blue for Vasoplegic Syndrome Postcardiac Surgery. Indian J Crit Care Med. 2018 Mar;22(3):168-173. doi: 10.4103/ijccm.IJCCM_494_17. PMID: 29657374; PMCID: PMC5879859.

  50. Rodriguez P, Jiang Z, Huang S, Shen Q, Duong TQ. Methylene blue treatment delays progression of perfusion-diffusion mismatch to infarct in permanent ischemic stroke. Brain Res. 2014 Nov 7;1588:144-9. doi: 10.1016/j.brainres.2014.09.007. Epub 2014 Sep 8. PMID: 25218555; PMCID: PMC4907336.

  51. Gillman PK. Methylene blue is a potent monoamine oxidase inhibitor. Can J Anaesth. 2008 May;55(5):311-2; author reply 312. doi: 10.1007/BF03017212. PMID: 18451123.

  52. Oxenkrug GF, Sablin SO, Requintina PJ. Effect of methylene blue and related redox dyes on monoamine oxidase activity; rat pineal content of N-acetylserotonin, melatonin, and related indoles; and righting reflex in melatonin-primed frogs. Ann N Y Acad Sci. 2007 Dec;1122:245-52. doi: 10.1196/annals.1403.017. PMID: 18077577.

  53. Delport A, Harvey BH, Petzer A, Petzer JP. The monoamine oxidase inhibition properties of selected structural analogues of methylene blue. Toxicol Appl Pharmacol. 2017 Jun 15;325:1-8. doi: 10.1016/j.taap.2017.03.026. Epub 2017 Apr 1. PMID: 28377303.

  54. Alda M. Methylene Blue in the Treatment of Neuropsychiatric Disorders. CNS Drugs. 2019 Aug;33(8):719-725. doi: 10.1007/s40263-019-00641-3. PMID: 31144270.

  55. Alda M, McKinnon M, Blagdon R, Garnham J, MacLellan S, O’Donovan C, Hajek T, Nair C, Dursun S, MacQueen G. Methylene blue treatment for residual symptoms of bipolar disorder: randomised crossover study. British Journal of Psychiatry. 2017 Jan;210(1):54-60. doi: 10.1192/bjp.bp.115.173930. Epub 2016 Jun 9. PMID: 27284082.

  56. Delport A, Harvey BH, Petzer A, Petzer JP. Methylene blue and its analogues as antidepressant compounds. Metab Brain Dis. 2017 Oct;32(5):1357-1382. doi: 10.1007/s11011-017-0081-6. Epub 2017 Jul 31. PMID: 28762173.

  57. Delport A, Harvey BH, Petzer A, Petzer JP. Methylene Blue Analogues with Marginal Monoamine Oxidase Inhibition Retain Antidepressant-like Activity. ACS Chem Neurosci. 2018 Dec 19;9(12):2917-2928. doi: 10.1021/acschemneuro.8b00042. Epub 2018 Jul 25. PMID: 29976053.

  58. Naylor GJ, Smith AH, Connelly P. A controlled trial of methylene blue in severe depressive illness. Biol Psychiatry. 1987 May;22(5):657-9. doi: 10.1016/0006-3223(87)90194-6. PMID: 3555627.

  59. Xiong ZM, O’Donovan M, Sun L, Choi JY, Ren M, Cao K. Anti-Aging Potentials of Methylene Blue for Human Skin Longevity. Sci Rep. 2017 May 30;7(1):2475. doi: 10.1038/s41598-017-02419-3. PMID: 28559565; PMCID: PMC5449383.

  60. Xiong ZM, Mao X, Trappio M, Arya C, Kordi JE, Cao K. Ultraviolet radiation protection potentials of Methylene Blue for human skin and coral reef health. Sci Rep. 2021 May 28;11(1):10871. doi: 10.1038/s41598-021-89970-2. PMID: 34050204; PMCID: PMC8163870.

  61. Samalavicius NE, Poskus T, Gupta RK, Lunevicius R. Long-term results of single intradermal 1 % methylene blue injection for intractable idiopathic pruritus ani: a prospective study. Tech Coloproctol. 2012 Aug;16(4):295-9. doi: 10.1007/s10151-012-0846-1. Epub 2012 Jun 6. PMID: 22669483.

  62. Scigliano G, Scigliano GA. Methylene blue in covid-19. Med Hypotheses. 2021 Jan;146:110455. doi: 10.1016/j.mehy.2020.110455. Epub 2020 Dec 10. PMID: 33341032; PMCID: PMC7728423.

  63. Dabholkar N, Gorantla S, Dubey SK, Alexander A, Taliyan R, Singhvi G. Repurposing methylene blue in the management of COVID-19: Mechanistic aspects and clinical investigations. Biomed Pharmacother. 2021 Oct;142:112023. doi: 10.1016/j.biopha.2021.112023. Epub 2021 Aug 10. PMID: 34399199; PMCID: PMC8352658.

  64. Gendrot M, Andreani J, Duflot I, Boxberger M, Le Bideau M, Mosnier J, Jardot P, Fonta I, Rolland C, Bogreau H, Hutter S, La Scola B, Pradines B. Methylene blue inhibits replication of SARS-CoV-2 in vitro. Int J Antimicrob Agents. 2020 Dec;56(6):106202. doi: 10.1016/j.ijantimicag.2020.106202. Epub 2020 Oct 16. PMID: 33075512; PMCID: PMC7566888.

  65. Arentz J, von der Heide HJ. Evaluation of methylene blue based photodynamic inactivation (PDI) against intracellular B-CoV and SARS-CoV2 viruses under different light sources in vitro as a basis for new local treatment strategies in the early phase of a Covid19 infection. Photodiagnosis Photodyn Ther. 2022 Mar;37:102642. doi: 10.1016/j.pdpdt.2021.102642. Epub 2021 Dec 2. PMID: 34863949; PMCID: PMC8635689.

  66. Gama CRB, Pombo MAG, Nunes CP, Gama GF, Mezitis SGE, Suchmacher Neto M, Guimarães OR, Geller M, Oliveira L, de Souza da Fonseca A, Sitnoveter A, Goldwasser G, Cunha KS, Darrigo Junior LG. Treatment of Recurrent Urinary Tract Infection Symptoms with Urinary Antiseptics Containing Methenamine and Methylene Blue: Analysis of Etiology and Treatment Outcomes. Res Rep Urol. 2020 Dec 15;12:639-649. doi: 10.2147/RRU.S279060. PMID: 33365282; PMCID: PMC7751791.

  67. Cagno V, Medaglia C, Cerny A, Cerny T, Zwygart AC, Cerny E, Tapparel C. Methylene Blue has a potent antiviral activity against SARS-CoV-2 and H1N1 influenza virus in the absence of UV-activation in vitro. Sci Rep. 2021 Jul 12;11(1):14295. doi: 10.1038/s41598-021-92481-9. PMID: 34253743; PMCID: PMC8275569.

  68. Shaw JD, Miller S, Plourde A, Shaw DL, Wustrack R, Hansen EN. Methylene Blue-Guided Debridement as an Intraoperative Adjunct for the Surgical Treatment of Periprosthetic Joint Infection. J Arthroplasty. 2017 Dec;32(12):3718-3723. doi: 10.1016/j.arth.2017.07.019. Epub 2017 Jul 21. PMID: 28811108.

  69. Ansari MA, Fatima Z, Hameed S. Antifungal Action of Methylene Blue Involves Mitochondrial Dysfunction and Disruption of Redox and Membrane Homeostasis in C. albicans. Open Microbiol J. 2016 Feb 25;10:12-22. doi: 10.2174/1874285801610010012. PMID: 27006725; PMCID: PMC4780517.]

  70. Steinmann E, Gravemann U, Friesland M, Doerrbecker J, Müller TH, Pietschmann T, Seltsam A. Two pathogen reduction technologies–methylene blue plus light and shortwave ultraviolet light–effectively inactivate hepatitis C virus in blood products. Transfusion. 2013 May;53(5):1010-8. doi: 10.1111/j.1537-2995.2012.03858.x. Epub 2012 Aug 21. PMID: 22905868.

  71. 10.  Li Z, Lang Y, Sakamuru S, Samrat S, Trudeau N, Kuo L, Rugenstein N, Tharappel A, D’Brant L, Koetzner CA, Hu S, Zhang J, Huang R, Kramer LD, Butler D, Xia M, Li H. Methylene blue is a potent and broad-spectrum inhibitor against Zika virus in vitro and in vivo. Emerg Microbes Infect. 2020 Dec;9(1):2404-2416. doi: 10.1080/22221751.2020.1838954. PMID: 33078696; PMCID: PMC7646565.

  72. Caffarel-Salvador E, Kearney MC, Mairs R, Gallo L, Stewart SA, Brady AJ, Donnelly RF. Methylene Blue-Loaded Dissolving Microneedles: Potential Use in Photodynamic Antimicrobial Chemotherapy of Infected Wounds. Pharmaceutics. 2015 Sep 28;7(4):397-412. doi: 10.3390/pharmaceutics7040397. PMID: 26426040; PMCID: PMC4695826.

  73. 12.  Zheng X, Ma X, Li T, Shi W, Zhang Y. Effect of different drugs and drug combinations on killing stationary phase and biofilms recovered cells of Bartonella henselae in vitro. BMC Microbiol. 2020 Apr 10;20(1):87. doi: 10.1186/s12866-020-01777-9. PMID: 32276590; PMCID: PMC7149919.

  74. Khanal A, Bui MP, Seo SS. Microgel-encapsulated methylene blue for the treatment of breast cancer cells by photodynamic therapy. J Breast Cancer. 2014 Mar;17(1):18-24. doi: 10.4048/jbc.2014.17.1.18. Epub 2014 Mar 28. PMID: 24744793; PMCID: PMC3988338.

  75. Sanchala D, Bhatt LK, Pethe P, Shelat R, Kulkarni YA. Anticancer activity of methylene blue via inhibition of heat shock protein 70. Biomed Pharmacother. 2018 Nov;107:1037-1045. doi: 10.1016/j.biopha.2018.08.095. Epub 2018 Aug 24. PMID: 30257315.

  76. Dos Santos AF, Terra LF, Wailemann RA, Oliveira TC, Gomes VM, Mineiro MF, Meotti FC, Bruni-Cardoso A, Baptista MS, Labriola L. Methylene blue photodynamic therapy induces selective and massive cell death in human breast cancer cells. BMC Cancer. 2017 Mar 15;17(1):194. doi: 10.1186/s12885-017-3179-7. PMID: 28298203; PMCID: PMC5353937.

  77. Roldan CJ, Chung M, Feng L, Bruera E. Methylene Blue for the Treatment of Intractable Pain From Oral Mucositis Related to Cancer Treatment: An Uncontrolled Cohort. J Natl Compr Canc Netw. 2021 Jan 4;19(5):521-527. doi: 10.6004/jnccn.2020.7651. PMID: 33395626.

  78. Müller O, Lu G, Jahn A, Mockenhaupt FP. How worthwhile is methylene blue as a treatment of malaria? Expert Rev Anti Infect Ther. 2019 Jul;17(7):471-473. doi: 10.1080/14787210.2019.1634545. Epub 2019 Jun 25. PMID: 31237457.

  79. Meissner PE, Mandi G, Coulibaly B, Witte S, Tapsoba T, Mansmann U, Rengelshausen J, Schiek W, Jahn A, Walter-Sack I, Mikus G, Burhenne J, Riedel KD, Schirmer RH, Kouyaté B, Müller O. Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine. Malar J. 2006 Oct 8;5:84. doi: 10.1186/1475-2875-5-84. PMID: 17026773; PMCID: PMC1617109.

  80. Lu G, Nagbanshi M, Goldau N, Mendes Jorge M, Meissner P, Jahn A, Mockenhaupt FP, Müller O. Efficacy and safety of methylene blue in the treatment of malaria: a systematic review. BMC Med. 2018 Apr 25;16(1):59. doi: 10.1186/s12916-018-1045-3. PMID: 29690878; PMCID: PMC5979000.

  81. Schirmer RH, Coulibaly B, Stich A, Scheiwein M, Merkle H, Eubel J, Becker K, Becher H, Müller O, Zich T, Schiek W, Kouyaté B. Methylene blue as an antimalarial agent. Redox Report. 2003;8(5):272-5. doi: 10.1179/135100003225002899. PMID: 14962363.

  82. Dormoi J, Amalvict R, Gendrot M, Pradines B. Methylene Blue-Based Combination Therapy with Amodiaquine Prevents Severe Malaria in an Experimental Rodent Model. Pharmaceutics. 2022 Sep 24;14(10):2031. doi: 10.3390/pharmaceutics14102031. PMID: 36297466; PMCID: PMC9611243.

  83. Pushparajah Mak RS, Liebelt EL. Methylene Blue: An Antidote for Methemoglobinemia and Beyond. Pediatr Emerg Care. 2021 Sep 1;37(9):474-477. doi: 10.1097/PEC.0000000000002526. PMID: 34463662.

  84. Iolascon A, Bianchi P, Andolfo I, Russo R, Barcellini W, Fermo E, Toldi G, Ghirardello S, Rees D, Van Wijk R, Kattamis A, Gallagher PG, Roy N, Taher A, Mohty R, Kulozik A, De Franceschi L, Gambale A, De Montalembert M, Forni GL, Harteveld CL, Prchal J; SWG of red cell and iron of EHA and EuroBloodNet. Recommendations for diagnosis and treatment of methemoglobinemia. Am J Hematol. 2021 Dec 1;96(12):1666-1678. doi: 10.1002/ajh.26340. Epub 2021 Sep 23. PMID: 34467556; PMCID: PMC9291883.

  85. Cefalu JN, Joshi TV, Spalitta MJ, Kadi CJ, Diaz JH, Eskander JP, Cornett EM, Kaye AD. Methemoglobinemia in the Operating Room and Intensive Care Unit: Early Recognition, Pathophysiology, and Management. Adv Ther. 2020 May;37(5):1714-1723. doi: 10.1007/s12325-020-01282-5. Epub 2020 Mar 19. PMID: 32193811; PMCID: PMC7467467.

Other Peptides

Hydrogen Water

NMN (Nicotinamide Mononucleotide)

5-amino-1MQ

Vasoactive Intestinal Peptide

Selank

Success Stories

men testimonial before after

At the age of 60, I look and feel better than I ever have in my entire life! Switching my health program and hormone replacement therapy regimen over to Genemedics was one of the best decisions I’ve ever made in my life! Genemedics and Dr George have significantly improved my quality of life and also dramatically improved my overall health. I hav...
Nick Cassavetes ,60 yrs old Movie Director (“The Notebook”, “John Q”, “Alpha Dog”), Actor and Writer

See All Men’s Testimonials

Call 800-277-4041 for a Free Consultation

What to expect during your consultation:
  • Usually takes 15-30 minutes
  • Completely confidential
  • No obligation to purchase anything
  • We will discuss your symptoms along with your health and fitness goals
  • Free post-consult access for any additional questions you may have

About

Genemedics® Health Institute is a global premier institute dedicated to revolutionizing health and medicine through healthy lifestyle education, guidance and accountability in harmony with functional medicine. Our physician-supervised health programs are personally customized to help you reach your health and fitness goals while looking and feeling better than ever.

Quick Links

Our Services

 Our Locations

genemedics logo

280 North Old Woodward Ave. Suite 210 Birmingham MI 48009,USA

800-277-4041

info@genemedics.com

© Copyright Genemedics Health Institute. All Rights Reserved. Privacy Policy.

Back to Top
-

Free Consultation

STEPS AWAY FROM A YOUNGER. HEALTHIER YOU!

Call 800-277-4041 for a Free Consultation

What to expect during your consultation:

  • Usually takes 15-30 minutes
  • Completely confidential
  • No obligation to purchase anything
  • We will discuss your symptoms along with your health and fitness goals
  • Free post-consult access for any additional questions you may have
Captch Background